{"id":"https://openalex.org/W1486590503","doi":null,"title":"[Enfuvirtide: the first step for a new strategy of antiretroviral therapy].","display_name":"[Enfuvirtide: the first step for a new strategy of antiretroviral therapy].","publication_year":2007,"publication_date":"2007-01-01","ids":{"openalex":"https://openalex.org/W1486590503","mag":"1486590503","pmid":"https://pubmed.ncbi.nlm.nih.gov/17593608"},"language":"es","primary_location":{"id":"pmid:17593608","doi":null,"is_oa":false,"landing_page_url":"https://pubmed.ncbi.nlm.nih.gov/17593608","pdf_url":null,"source":{"id":"https://openalex.org/S4306525036","display_name":"PubMed","issn_l":null,"issn":null,"is_oa":false,"is_in_doaj":false,"is_core":false,"listed_in":[],"host_organization":"https://openalex.org/I1299303238","host_organization_name":"National Institutes of Health","host_organization_lineage":["https://openalex.org/I1299303238"],"host_organization_lineage_names":[],"type":"repository"},"license":null,"license_id":null,"version":"publishedVersion","is_accepted":true,"is_published":true,"raw_source_name":"Medicina","raw_type":"Journal Article"},"volume":null,"type":"article","is_traditional":true,"indexed_in":["pubmed"],"open_access":{"is_oa":false,"oa_status":"closed","oa_url":null,"any_repository_has_fulltext":false},"authorships":[{"author_position":"first","author":{"id":"https://openalex.org/A5078222616","display_name":"Edgardo Gabriel Bottaro","orcid":"https://orcid.org/0009-0001-0602-5175","observed_orcids":["https://orcid.org/0009-0001-0602-5175"]},"institutions":[{"id":"https://openalex.org/I4210131631","display_name":"Helios Salud","ror":"https://ror.org/037vec356","country_code":"AR","type":"healthcare","lineage":["https://openalex.org/I4210131631"]},{"id":"https://openalex.org/I4210133262","display_name":"Hospital Donaci\u00f3n Francisco Santojanni","ror":"https://ror.org/03qmdb045","country_code":"AR","type":"healthcare","lineage":["https://openalex.org/I4210133262"]}],"countries":["AR"],"is_corresponding":true,"raw_author_name":"Edgardo G Bottaro","raw_affiliation_strings":["Helios Salud, Hospital General de Agudos Donaci\u00f3n F. Santojanni, Buenos Aires. egbottaro@gmail.com"],"raw_orcid":null,"affiliations":[{"raw_affiliation_string":"Helios Salud, Hospital General de Agudos Donaci\u00f3n F. Santojanni, Buenos Aires. egbottaro@gmail.com","institution_ids":["https://openalex.org/I4210131631","https://openalex.org/I4210133262"]}]}],"institutions":[],"countries_distinct_count":1,"institutions_distinct_count":2,"corresponding_author_ids":["https://openalex.org/A5078222616"],"corresponding_institution_ids":["https://openalex.org/I4210131631","https://openalex.org/I4210133262"],"apc_list":null,"apc_paid":null,"fwci":0.4304,"has_fulltext":false,"cited_by_count":3,"citation_normalized_percentile":{"value":0.6480911,"is_in_top_1_percent":false,"is_in_top_10_percent":false},"cited_by_percentile_year":{"min":88,"max":93},"biblio":{"volume":"67","issue":"2","first_page":"195","last_page":"205"},"is_retracted":false,"is_paratext":false,"is_xpac":false,"primary_topic":{"id":"https://openalex.org/T10526","display_name":"HIV/AIDS drug development and treatment","score":0.9994999766349792,"subfield":{"id":"https://openalex.org/subfields/2725","display_name":"Infectious Diseases"},"field":{"id":"https://openalex.org/fields/27","display_name":"Medicine"},"domain":{"id":"https://openalex.org/domains/4","display_name":"Health Sciences"}},"topics":[{"id":"https://openalex.org/T10526","display_name":"HIV/AIDS drug development and treatment","score":0.9994999766349792,"subfield":{"id":"https://openalex.org/subfields/2725","display_name":"Infectious Diseases"},"field":{"id":"https://openalex.org/fields/27","display_name":"Medicine"},"domain":{"id":"https://openalex.org/domains/4","display_name":"Health Sciences"}},{"id":"https://openalex.org/T10112","display_name":"HIV Research and Treatment","score":0.0003000000142492354,"subfield":{"id":"https://openalex.org/subfields/2406","display_name":"Virology"},"field":{"id":"https://openalex.org/fields/24","display_name":"Immunology and Microbiology"},"domain":{"id":"https://openalex.org/domains/1","display_name":"Life Sciences"}},{"id":"https://openalex.org/T10082","display_name":"HIV/AIDS Research and Interventions","score":9.999999747378752e-05,"subfield":{"id":"https://openalex.org/subfields/2725","display_name":"Infectious Diseases"},"field":{"id":"https://openalex.org/fields/27","display_name":"Medicine"},"domain":{"id":"https://openalex.org/domains/4","display_name":"Health Sciences"}}],"keywords":[{"id":"https://openalex.org/keywords/enfuvirtide","display_name":"enfuvirtide","score":0.9980000257492065},{"id":"https://openalex.org/keywords/hiv-1-entry-inhibitors","display_name":"HIV-1 entry inhibitors","score":0.8529999852180481},{"id":"https://openalex.org/keywords/gp41","display_name":"gp41","score":0.7379999756813049},{"id":"https://openalex.org/keywords/antiretroviral-therapy","display_name":"antiretroviral therapy","score":0.8230000138282776},{"id":"https://openalex.org/keywords/virologic-failure","display_name":"virological failure","score":0.7770000100135803},{"id":"https://openalex.org/keywords/drug-resistance","display_name":"drug resistance","score":0.6159999966621399},{"id":"https://openalex.org/keywords/highly-active-antiretroviral-therapy","display_name":"highly active antiretroviral therapy","score":0.8579999804496765},{"id":"https://openalex.org/keywords/viral-load","display_name":"viral load","score":0.8080000281333923},{"id":"https://openalex.org/keywords/cd4-count","display_name":"CD4 count","score":0.9210000038146973},{"id":"https://openalex.org/keywords/hypersensitivity","display_name":"hypersensitivity","score":0.7350000143051147},{"id":"https://openalex.org/keywords/cost-effectiveness","display_name":"cost-effectiveness","score":0.5490000247955322}],"concepts":[{"id":"https://openalex.org/C2778037500","wikidata":"https://www.wikidata.org/wiki/Q423327","display_name":"Enfuvirtide","level":5,"score":0.9981714487075806},{"id":"https://openalex.org/C2776258796","wikidata":"https://www.wikidata.org/wiki/Q5590520","display_name":"Gp41","level":4,"score":0.9316861629486084},{"id":"https://openalex.org/C142462285","wikidata":"https://www.wikidata.org/wiki/Q2528140","display_name":"Viral load","level":3,"score":0.5982670187950134},{"id":"https://openalex.org/C71924100","wikidata":"https://www.wikidata.org/wiki/Q11190","display_name":"Medicine","level":0,"score":0.5955377817153931},{"id":"https://openalex.org/C159047783","wikidata":"https://www.wikidata.org/wiki/Q7215","display_name":"Virology","level":1,"score":0.557228684425354},{"id":"https://openalex.org/C108625454","wikidata":"https://www.wikidata.org/wiki/Q187126","display_name":"Glycoprotein","level":2,"score":0.4522075355052948},{"id":"https://openalex.org/C535046627","wikidata":"https://www.wikidata.org/wiki/Q30612","display_name":"Clinical trial","level":2,"score":0.447290301322937},{"id":"https://openalex.org/C114851261","wikidata":"https://www.wikidata.org/wiki/Q12147416","display_name":"Drug resistance","level":2,"score":0.4256877601146698},{"id":"https://openalex.org/C2776997796","wikidata":"https://www.wikidata.org/wiki/Q1345259","display_name":"Entry inhibitor","level":5,"score":0.41956132650375366},{"id":"https://openalex.org/C3013748606","wikidata":"https://www.wikidata.org/wiki/Q15787","display_name":"Human immunodeficiency virus (HIV)","level":2,"score":0.41040733456611633},{"id":"https://openalex.org/C98274493","wikidata":"https://www.wikidata.org/wiki/Q128406","display_name":"Pharmacology","level":1,"score":0.40269601345062256},{"id":"https://openalex.org/C203014093","wikidata":"https://www.wikidata.org/wiki/Q101929","display_name":"Immunology","level":1,"score":0.3757232427597046},{"id":"https://openalex.org/C2522874641","wikidata":"https://www.wikidata.org/wiki/Q808","display_name":"Virus","level":2,"score":0.34568122029304504},{"id":"https://openalex.org/C126322002","wikidata":"https://www.wikidata.org/wiki/Q11180","display_name":"Internal medicine","level":1,"score":0.3424875736236572},{"id":"https://openalex.org/C58475186","wikidata":"https://www.wikidata.org/wiki/Q4118894","display_name":"Viral entry","level":4,"score":0.2920083999633789},{"id":"https://openalex.org/C140704245","wikidata":"https://www.wikidata.org/wiki/Q3933202","display_name":"Viral replication","level":3,"score":0.2286321520805359},{"id":"https://openalex.org/C86803240","wikidata":"https://www.wikidata.org/wiki/Q420","display_name":"Biology","level":0,"score":0.2163357138633728},{"id":"https://openalex.org/C147483822","wikidata":"https://www.wikidata.org/wiki/Q103537","display_name":"Antigen","level":2,"score":0.14514833688735962},{"id":"https://openalex.org/C195616568","wikidata":"https://www.wikidata.org/wiki/Q128711","display_name":"Epitope","level":3,"score":0.08843556046485901},{"id":"https://openalex.org/C153911025","wikidata":"https://www.wikidata.org/wiki/Q7202","display_name":"Molecular biology","level":1,"score":0.0740390419960022},{"id":"https://openalex.org/C89423630","wikidata":"https://www.wikidata.org/wiki/Q7193","display_name":"Microbiology","level":1,"score":0.0}],"mesh":[{"descriptor_ui":"D000077560","descriptor_name":"Enfuvirtide","qualifier_ui":null,"qualifier_name":null,"is_major_topic":false},{"descriptor_ui":"D006801","descriptor_name":"Humans","qualifier_ui":null,"qualifier_name":null,"is_major_topic":false},{"descriptor_ui":"D010446","descriptor_name":"Peptide Fragments","qualifier_ui":"Q000009","qualifier_name":"adverse effects","is_major_topic":false},{"descriptor_ui":"D010446","descriptor_name":"Peptide Fragments","qualifier_ui":"Q000627","qualifier_name":"therapeutic use","is_major_topic":true},{"descriptor_ui":"D015497","descriptor_name":"HIV-1","qualifier_ui":"Q000187","qualifier_name":"drug effects","is_major_topic":true},{"descriptor_ui":"D015658","descriptor_name":"HIV Infections","qualifier_ui":"Q000188","qualifier_name":"drug therapy","is_major_topic":true},{"descriptor_ui":"D015658","descriptor_name":"HIV Infections","qualifier_ui":"Q000821","qualifier_name":"virology","is_major_topic":false},{"descriptor_ui":"D015700","descriptor_name":"HIV Envelope Protein gp41","qualifier_ui":"Q000009","qualifier_name":"adverse effects","is_major_topic":false},{"descriptor_ui":"D015700","descriptor_name":"HIV Envelope Protein gp41","qualifier_ui":"Q000627","qualifier_name":"therapeutic use","is_major_topic":true},{"descriptor_ui":"D015704","descriptor_name":"CD4 Antigens","qualifier_ui":"Q000187","qualifier_name":"drug effects","is_major_topic":false},{"descriptor_ui":"D017211","descriptor_name":"Treatment Failure","qualifier_ui":null,"qualifier_name":null,"is_major_topic":false},{"descriptor_ui":"D018791","descriptor_name":"CD4 Lymphocyte Count","qualifier_ui":null,"qualifier_name":null,"is_major_topic":false},{"descriptor_ui":"D019562","descriptor_name":"Viral Load","qualifier_ui":null,"qualifier_name":null,"is_major_topic":false},{"descriptor_ui":"D023241","descriptor_name":"Antiretroviral Therapy, Highly Active","qualifier_ui":null,"qualifier_name":null,"is_major_topic":false},{"descriptor_ui":"D023581","descriptor_name":"HIV Fusion Inhibitors","qualifier_ui":"Q000009","qualifier_name":"adverse effects","is_major_topic":false},{"descriptor_ui":"D023581","descriptor_name":"HIV Fusion Inhibitors","qualifier_ui":"Q000627","qualifier_name":"therapeutic use","is_major_topic":true},{"descriptor_ui":"D024882","descriptor_name":"Drug Resistance, Viral","qualifier_ui":null,"qualifier_name":null,"is_major_topic":false}],"locations_count":2,"locations":[{"id":"pmid:17593608","doi":null,"is_oa":false,"landing_page_url":"https://pubmed.ncbi.nlm.nih.gov/17593608","pdf_url":null,"source":{"id":"https://openalex.org/S4306525036","display_name":"PubMed","issn_l":null,"issn":null,"is_oa":false,"is_in_doaj":false,"is_core":false,"listed_in":[],"host_organization":"https://openalex.org/I1299303238","host_organization_name":"National Institutes of Health","host_organization_lineage":["https://openalex.org/I1299303238"],"host_organization_lineage_names":[],"type":"repository"},"license":null,"license_id":null,"version":"publishedVersion","is_accepted":true,"is_published":true,"raw_source_name":"Medicina","raw_type":"Journal Article"},{"id":"mag:1486590503","doi":null,"is_oa":false,"landing_page_url":"https://pubmed.ncbi.nlm.nih.gov/17593608","pdf_url":null,"source":{"id":"https://openalex.org/S4306525036","display_name":"PubMed","issn_l":null,"issn":null,"is_oa":false,"is_in_doaj":false,"is_core":false,"listed_in":[],"host_organization":"https://openalex.org/I1299303238","host_organization_name":"National Institutes of Health","host_organization_lineage":["https://openalex.org/I1299303238"],"host_organization_lineage_names":[],"type":"repository"},"license":null,"license_id":null,"version":null,"is_accepted":false,"is_published":false,"raw_source_name":"PubMed","raw_type":null}],"best_oa_location":null,"sustainable_development_goals":[{"display_name":"Good health and well-being","score":0.9763000011444092,"id":"https://metadata.un.org/sdg/3"}],"study_designs":[],"awards":[],"funders":[],"has_content":{"grobid_xml":false,"pdf":false},"content_urls":null,"referenced_works_count":46,"referenced_works":["https://openalex.org/W82820957","https://openalex.org/W1965987174","https://openalex.org/W1981440980","https://openalex.org/W1981644527","https://openalex.org/W1986159600","https://openalex.org/W1988809071","https://openalex.org/W1991665327","https://openalex.org/W1999623844","https://openalex.org/W2006380986","https://openalex.org/W2006880855","https://openalex.org/W2010387580","https://openalex.org/W2017551575","https://openalex.org/W2023155031","https://openalex.org/W2032020323","https://openalex.org/W2034053987","https://openalex.org/W2036192699","https://openalex.org/W2040506631","https://openalex.org/W2040506780","https://openalex.org/W2047160382","https://openalex.org/W2056461111","https://openalex.org/W2067464226","https://openalex.org/W2073079322","https://openalex.org/W2077776684","https://openalex.org/W2085739552","https://openalex.org/W2086725873","https://openalex.org/W2091078658","https://openalex.org/W2101403311","https://openalex.org/W2107672429","https://openalex.org/W2112419344","https://openalex.org/W2119551786","https://openalex.org/W2120064320","https://openalex.org/W2124488515","https://openalex.org/W2128574780","https://openalex.org/W2129106897","https://openalex.org/W2130998191","https://openalex.org/W2133649749","https://openalex.org/W2135072010","https://openalex.org/W2137623184","https://openalex.org/W2146478787","https://openalex.org/W2147308092","https://openalex.org/W2148591835","https://openalex.org/W2153747683","https://openalex.org/W2155493878","https://openalex.org/W2172221687","https://openalex.org/W2241071176","https://openalex.org/W2312642584"],"related_works":["https://openalex.org/W4232059684","https://openalex.org/W2160633544","https://openalex.org/W2053239804","https://openalex.org/W2415990817","https://openalex.org/W2074694215","https://openalex.org/W2083720026","https://openalex.org/W2112419344","https://openalex.org/W2133649749","https://openalex.org/W186756043","https://openalex.org/W2119551786"],"abstract_inverted_index":{"Enfuvirtide":[0],"(T-20)":[1],"is":[2,12,34,69,172,187],"the":[3,25,35,42,45,53,62,65,103,137,149,152,173],"first":[4],"approved":[5],"HIV-1":[6],"entry":[7],"into":[8],"cells'":[9],"inhibitor.":[10],"It":[11],"a":[13,113,155,160,190],"peptide":[14],"with":[15,64,88,112,141],"an":[16,108],"amino":[17],"acid":[18],"sequence":[19],"analogue":[20],"to":[21,38,107,148],"HR2":[22,50],"region":[23,40],"of":[24,32,41,61,77,105,139,151,175,182],"viral":[26,97,126,157],"surface":[27],"glycoprotein":[28],"gp41.":[29],"Its":[30,67],"mechanism":[31],"action":[33],"competitive":[36],"binding":[37],"HR1":[39,48],"gp41,":[43],"preventing":[44],"interaction":[46],"between":[47],"and":[49,51,81,94,128,159],"impeding":[52],"conformational":[54],"changes":[55],"in":[56,85,125,136,145,180,192],"gp41":[57],"necessary":[58],"for":[59],"fusion":[60],"virus":[63],"cell.":[66],"application":[68],"by":[70,123,189],"subcutaneous":[71],"injection.":[72],"The":[73,131,167,184],"main":[74],"clinical":[75],"trials":[76,100],"enfuvirtide":[78,106],"(TORO":[79],"1":[80],"2)":[82],"were":[83,134],"performed":[84],"HIV-infected":[86],"patients":[87,140],"virological":[89],"failure,":[90],"high":[91,185],"antiretroviral":[92],"experience":[93],"highly":[95],"resistant":[96],"isolates.":[98],"Those":[99],"showed":[101],"that":[102],"addition":[104],"optimized":[109],"HAART":[110,120,146],"(chosen":[111],"resistance":[114,153],"test)":[115],"provided":[116],"better":[117],"results":[118,133],"than":[119],"alone,":[121],"measured":[122],"drop":[124],"load":[127],"immunologic":[129],"benefit.":[130],"best":[132],"observed":[135],"subgroup":[138],"more":[142],"useful":[143],"drugs":[144],"(according":[147],"information":[150],"test),":[154],"lower":[156],"load,":[158],"higher":[161],"CD4":[162],"cell":[163],"count":[164],"at":[165],"baseline.":[166],"most":[168],"important":[169],"adverse":[170],"event":[171],"production":[174],"injection":[176],"drug":[177],"hypersensitivity":[178],"reaction":[179],"98%":[181],"patients.":[183],"cost":[186],"compensated":[188],"reduction":[191],"costs":[193],"derived":[194],"from":[195],"admissions.":[196]},"counts_by_year":[{"year":2014,"cited_by_count":1}],"updated_date":"2026-10-31T12:09:11.096373","created_date":"2016-06-24T00:00:00"}